Despite the implication of OPN in pathways relevant to atherosclerosis, few studies have investigated whether levels of OPN are associated with adverse cardiovascular outcomes in patients with known cardiovascular disease [14,15,16]. The gene discussed is SPP1; the disease is cardiovascular disorder.